Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases

BACKGROUND: We previously reported mass spectrometry-based proteomic discovery research to identify novel plasma proteins related to the risk of coronary heart disease (CHD) and stroke, and to identify proteins with concentrations affected by the use of postmenopausal hormone therapy. Here we report...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Prentice, Ross L, Zhao, Shanshan, Johnson, Melissa, Aragaki, Aaron, Hsia, Judith, Jackson, Rebecca D, Rossouw, Jacques E, Manson, JoAnn E, Hanash, Samir M
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2013
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971342/
https://ncbi.nlm.nih.gov/pubmed/24373343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/gm517
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk